Search research articles
Contact Us
Filters
Showing results (21-30 of 162) with videos related to
Page
of 17
Sort By:
Neuroepidemiology
|
January 1, 1991
Smoking and stroke
M Higa, Z Davanipour
AMB : Revista Da Associacao Medica Brasileira
|
September 1, 1987
[Drug nephrotoxicities]
E M Higa, N Schor
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
April 2, 1998
Anastrozole: a selective aromatase inhibitor for the treatment of breast cancer
G M Higa, N alKhouri
Expert Review of Anticancer Therapy
|
July 11, 2009
Biological mechanisms of bevacizumab-associated adverse events
Gerald M Higa, Jame Abraham
Clinical Medicine Insights. Oncology
|
April 16, 2016
Molecular Biology and Clinical Mitigation of Cancer Treatment-Induced Neuropathy
Gerald M Higa, Corbin Sypult
Expert Review of Anticancer Therapy
|
September 26, 2007
Lapatinib in the treatment of breast cancer
Gerald M Higa, Jame Abraham
Expert Review of Anticancer Therapy
|
May 13, 2008
Ixabepilone: a new microtubule-targeting agent for breast cancer
Gerald M Higa, Jame Abraham
Clinical Pharmacy
|
December 1, 1987
Alterations in aminoglycoside pharmacokinetics in patients with cancer
G M Higa, W E Murray
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society
|
August 21, 2001
[A case of acute pulmonary embolism associated with squatting]
M Higa, S Ohnuma, K Shimizu
International Journal of Breast Cancer
|
December 11, 2013
Sex hormone receptor repertoire in breast cancer
Gerald M Higa, Ryan G Fell
Page
of 17
Search research articles
Search
Showing results (21-30 of 162) with videos related to
Sort By:
Page
of 17
Neuroepidemiology
|
January 1, 1991
Smoking and stroke
M Higa, Z Davanipour
AMB : Revista Da Associacao Medica Brasileira
|
September 1, 1987
[Drug nephrotoxicities]
E M Higa, N Schor
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
April 2, 1998
Anastrozole: a selective aromatase inhibitor for the treatment of breast cancer
G M Higa, N alKhouri
Expert Review of Anticancer Therapy
|
July 11, 2009
Biological mechanisms of bevacizumab-associated adverse events
Gerald M Higa, Jame Abraham
Clinical Medicine Insights. Oncology
|
April 16, 2016
Molecular Biology and Clinical Mitigation of Cancer Treatment-Induced Neuropathy
Gerald M Higa, Corbin Sypult
Expert Review of Anticancer Therapy
|
September 26, 2007
Lapatinib in the treatment of breast cancer
Gerald M Higa, Jame Abraham
Expert Review of Anticancer Therapy
|
May 13, 2008
Ixabepilone: a new microtubule-targeting agent for breast cancer
Gerald M Higa, Jame Abraham
Clinical Pharmacy
|
December 1, 1987
Alterations in aminoglycoside pharmacokinetics in patients with cancer
G M Higa, W E Murray
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society
|
August 21, 2001
[A case of acute pulmonary embolism associated with squatting]
M Higa, S Ohnuma, K Shimizu
International Journal of Breast Cancer
|
December 11, 2013
Sex hormone receptor repertoire in breast cancer
Gerald M Higa, Ryan G Fell
Page
of 17